Abirateron Fresenius Kabi 500 mg filmomh. tabl. Belgija - nizozemščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

abirateron fresenius kabi 500 mg filmomh. tabl.

fresenius kabi sa-nv - abirateronacetaat 500 mg - filmomhulde tablet - abiraterone

Bixodalan 1 000 mg filmomh. tabl. Belgija - nizozemščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bixodalan 1 000 mg filmomh. tabl.

sandoz sa-nv - abirateronacetaat 1000 mg - filmomhulde tablet - abiraterone

Degarelix Accord Evropska unija - nizozemščina - EMA (European Medicines Agency)

degarelix accord

accord healthcare s.l.u. - degarelix acetate - prostaatnoplasma - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Orgovyx Evropska unija - nizozemščina - EMA (European Medicines Agency)

orgovyx

accord healthcare s.l.u. - relugolix - prostaatnoplasma - endocriene therapie - orgovyx is indicated for the treatment of adult patients with advanced hormone-sensitive prostate cancer.

Abiraterone Accord Evropska unija - nizozemščina - EMA (European Medicines Agency)

abiraterone accord

accord healthcare s.l.u. - abirateronacetaat - prostaatnoplasma - endocriene therapie - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Bixodalan 250 mg filmomh. tabl. Belgija - nizozemščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bixodalan 250 mg filmomh. tabl.

sandoz sa-nv - abirateronacetaat 250 mg - filmomhulde tablet - 250 mg - abirateronacetaat 250 mg - abiraterone

Bixodalan 500 mg filmomh. tabl. Belgija - nizozemščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bixodalan 500 mg filmomh. tabl.

sandoz sa-nv - abirateronacetaat 500 mg - filmomhulde tablet - 500 mg - abirateronacetaat 500 mg - abiraterone

Abiraterone Mylan Evropska unija - nizozemščina - EMA (European Medicines Agency)

abiraterone mylan

mylan ireland limited - abirateronacetaat - prostaatnoplasma - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Abirateron Teva 500 mg filmomh. tabl. Belgija - nizozemščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

abirateron teva 500 mg filmomh. tabl.

teva b.v. - abirateronacetaat 500 mg - filmomhulde tablet - abiraterone

Bixodalan 250 mg filmomh. tabl. Belgija - nizozemščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bixodalan 250 mg filmomh. tabl.

sandoz sa-nv - abirateronacetaat 250 mg - filmomhulde tablet - abiraterone